Marc Schegerin
Director of Finance/CFO bij MORPHIC HOLDING, INC.
Vermogen: 1 M $ op 29-02-2024
Profiel
Currently, Marc Schegerin occupies the position of Chief Operating & Financial Officer of Morphic Holding, Inc. and Chief Financial & Operating Officer at Morphic Therapeutic, Inc. (a subsidiary of Morphic Holding, Inc.).
He is also on the board of SQZ Biotechnologies Co.
In his past career Dr. Schegerin was Program Director at Biogen, Inc. and Chief Financial Officer, Treasurer & Head-Strategy at ArQule, Inc.
Dr. Schegerin received a doctorate from Dartmouth Medical School, an MBA from Tuck School of Business at Dartmouth, an undergraduate degree from Tulane University (Louisiana) and an undergraduate degree from Harvard University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MORPHIC HOLDING, INC.
0.07% | 16-01-2024 | 37 460 ( 0.07% ) | 1 M $ | 29-02-2024 |
31-12-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Marc Schegerin
Bedrijven | Functie | Begin |
---|---|---|
MORPHIC HOLDING, INC. | Director of Finance/CFO | 06-04-2020 |
SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 23-10-2020 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director of Finance/CFO | 01-04-2020 |
Eerdere bekende functies van Marc Schegerin
Bedrijven | Functie | Einde |
---|---|---|
ARQULE, INC. | Director of Finance/CFO | 01-01-2020 |
CITIGROUP INC. | Director/Board Member | 01-04-2018 |
SAGE THERAPEUTICS, INC. | Director/Board Member | 01-01-2014 |
BIOGEN INC. | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Marc Schegerin
Harvard University | Undergraduate Degree |
Tulane University (Louisiana) | Undergraduate Degree |
Dartmouth Medical School | Doctorate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
BIOGEN INC. | Health Technology |
CITIGROUP INC. | Finance |
SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
MORPHIC HOLDING, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |